HUP0204297A2 - (-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil)-piperidinil]-4H-1-benzopirán-4-on etanolos szolvátja, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények - Google Patents
(-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil)-piperidinil]-4H-1-benzopirán-4-on etanolos szolvátja, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0204297A2 HUP0204297A2 HU0204297A HUP0204297A HUP0204297A2 HU P0204297 A2 HUP0204297 A2 HU P0204297A2 HU 0204297 A HU0204297 A HU 0204297A HU P0204297 A HUP0204297 A HU P0204297A HU P0204297 A2 HUP0204297 A2 HU P0204297A2
- Authority
- HU
- Hungary
- Prior art keywords
- benzopyran
- piperidinyl
- chlorophenyl
- dihydroxy
- cis
- Prior art date
Links
- 239000012453 solvate Substances 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003386 piperidinyl group Chemical group 0.000 title 1
- 230000004048 modification Effects 0.000 abstract 2
- 238000012986 modification Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48781500A | 2000-01-18 | 2000-01-18 | |
PCT/US2001/000520 WO2001053294A1 (en) | 2000-01-18 | 2001-01-08 | Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0204297A2 true HUP0204297A2 (hu) | 2003-04-28 |
HUP0204297A3 HUP0204297A3 (en) | 2005-04-28 |
HU225155B1 HU225155B1 (en) | 2006-07-28 |
Family
ID=23937213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0204297A HU225155B1 (en) | 2000-01-18 | 2001-01-08 | Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one-hydrochloride, process for its preparation and pharmaceutical compositions containing it |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1252155B1 (hu) |
JP (1) | JP2003520798A (hu) |
KR (1) | KR100825530B1 (hu) |
CN (1) | CN1395577A (hu) |
AR (1) | AR027226A1 (hu) |
AT (1) | ATE284400T1 (hu) |
AU (1) | AU2001230869A1 (hu) |
BR (1) | BR0107724A (hu) |
CA (1) | CA2397594C (hu) |
CZ (1) | CZ301235B6 (hu) |
DE (1) | DE60107652T2 (hu) |
DK (1) | DK1252155T3 (hu) |
EA (1) | EA005182B1 (hu) |
ES (1) | ES2228800T3 (hu) |
HU (1) | HU225155B1 (hu) |
IL (2) | IL150643A0 (hu) |
MX (1) | MXPA02006965A (hu) |
NO (1) | NO322626B1 (hu) |
NZ (1) | NZ520281A (hu) |
PL (1) | PL201690B1 (hu) |
PT (1) | PT1252155E (hu) |
SI (1) | SI1252155T1 (hu) |
SK (1) | SK287216B6 (hu) |
TW (1) | TWI293072B (hu) |
WO (1) | WO2001053294A1 (hu) |
ZA (1) | ZA200205640B (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3503923B1 (en) | 2016-08-23 | 2023-10-04 | Eisai R&D Management Co., Ltd. | Combination therapies for the treatment of hepatocellular carcinoma |
AU2018234903B2 (en) | 2017-03-16 | 2024-02-08 | Eisai R&D Management Co., Ltd. | Combination therapies for the treatment of breast cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN164232B (hu) * | 1986-04-11 | 1989-02-04 | Hoechst India | |
US5284856A (en) * | 1988-10-28 | 1994-02-08 | Hoechst Aktiengesellschaft | Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives |
DE3836676A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
US5908934A (en) * | 1996-09-26 | 1999-06-01 | Bristol-Myers Squibb Company | Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs |
-
2001
- 2001-01-08 CN CN01803857A patent/CN1395577A/zh active Pending
- 2001-01-08 JP JP2001553768A patent/JP2003520798A/ja active Pending
- 2001-01-08 EP EP01902993A patent/EP1252155B1/en not_active Expired - Lifetime
- 2001-01-08 BR BR0107724-4A patent/BR0107724A/pt not_active Application Discontinuation
- 2001-01-08 KR KR1020027009140A patent/KR100825530B1/ko not_active IP Right Cessation
- 2001-01-08 SK SK1037-2002A patent/SK287216B6/sk not_active IP Right Cessation
- 2001-01-08 MX MXPA02006965A patent/MXPA02006965A/es active IP Right Grant
- 2001-01-08 WO PCT/US2001/000520 patent/WO2001053294A1/en active IP Right Grant
- 2001-01-08 ES ES01902993T patent/ES2228800T3/es not_active Expired - Lifetime
- 2001-01-08 CA CA2397594A patent/CA2397594C/en not_active Expired - Fee Related
- 2001-01-08 HU HU0204297A patent/HU225155B1/hu not_active IP Right Cessation
- 2001-01-08 CZ CZ20022467A patent/CZ301235B6/cs not_active IP Right Cessation
- 2001-01-08 SI SI200130293T patent/SI1252155T1/xx unknown
- 2001-01-08 AU AU2001230869A patent/AU2001230869A1/en not_active Abandoned
- 2001-01-08 AT AT01902993T patent/ATE284400T1/de active
- 2001-01-08 PT PT01902993T patent/PT1252155E/pt unknown
- 2001-01-08 PL PL355992A patent/PL201690B1/pl not_active IP Right Cessation
- 2001-01-08 DK DK01902993T patent/DK1252155T3/da active
- 2001-01-08 IL IL15064301A patent/IL150643A0/xx unknown
- 2001-01-08 EA EA200200776A patent/EA005182B1/ru not_active IP Right Cessation
- 2001-01-08 DE DE60107652T patent/DE60107652T2/de not_active Expired - Lifetime
- 2001-01-08 NZ NZ520281A patent/NZ520281A/en not_active IP Right Cessation
- 2001-01-17 AR ARP010100186A patent/AR027226A1/es not_active Application Discontinuation
- 2001-01-17 TW TW090101052A patent/TWI293072B/zh not_active IP Right Cessation
-
2002
- 2002-07-08 IL IL150643A patent/IL150643A/en not_active IP Right Cessation
- 2002-07-12 NO NO20023385A patent/NO322626B1/no not_active IP Right Cessation
- 2002-07-15 ZA ZA200205640A patent/ZA200205640B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203257A2 (hu) | Atorvastatin kalcium polimorf módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
CA2400268A1 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
HUP0105437A2 (hu) | Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0104718A2 (hu) | Mikronizált eplerenon kompozíciók és eljárás az előállításukra | |
NO995006D0 (no) | Nye forbindelser | |
HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
DE69904302D1 (de) | Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung | |
HUP0303653A2 (hu) | Tri-heterociklusos származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények | |
HUP9603237A2 (hu) | (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények | |
ATE386725T1 (de) | Heterocyclylverbindungen | |
HUP9802762A2 (hu) | Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
HUP0303639A2 (hu) | Új amlodipin-kamzilát és eljárás annak előállítására | |
HUP0302874A2 (hu) | Eljárás risperidon előállítására | |
HUP0104647A2 (hu) | Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény | |
CA2412047A1 (en) | Shortened synthesis of 3,3-diarylpropylamine derivatives | |
TNSN04024A1 (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation | |
HUP0300972A2 (hu) | Gatifloxacin-pentahidrát | |
AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
HUP0301082A2 (hu) | Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk | |
MY128890A (en) | Pyrrolidine oxadiazole- and thiadiazole derivatives | |
HUP0300863A2 (hu) | N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény | |
HUP0400889A2 (hu) | Eljárások (R)-alfa-(2,3-dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol előállítására és a vegyületet tartalmazó gyógyszerkészítmények | |
HUP0004900A2 (hu) | Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények | |
HUP0204297A2 (hu) | (-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil)-piperidinil]-4H-1-benzopirán-4-on etanolos szolvátja, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények | |
HUP0401234A2 (hu) | Pravastatin stabil gyógyászati kompozíciója és eljárás az előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU Representative=s name: RATHONYI ZOLTAN, S.B.G. & K. SZABADALMI UEGYVI, HU |
|
FH92 | Termination of representative |
Representative=s name: BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVI, HU |
|
GB9A | Succession in title |
Owner name: AVENTISUB II INC., US Free format text: FORMER OWNER(S): AVENTIS PHARMACEUTICALS INC., US |
|
FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): S.B.G. & K. SZABADALMI ES UEGYVEDI IRODAK, HU Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU |
|
FH92 | Termination of representative |
Representative=s name: S.B.G. & K. SZABADALMI ES UEGYVEDI IRODAK, HU |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |